|  Help  |  About  |  Contact Us

Publication : Chd2 interacts with H3.3 to determine myogenic cell fate.

First Author  Harada A Year  2012
Journal  EMBO J Volume  31
Issue  13 Pages  2994-3007
PubMed ID  22569126 Mgi Jnum  J:204624
Mgi Id  MGI:5532896 Doi  10.1038/emboj.2012.136
Citation  Harada A, et al. (2012) Chd2 interacts with H3.3 to determine myogenic cell fate. EMBO J 31(13):2994-3007
abstractText  Cell differentiation is mediated by lineage-determining transcription factors. We show that chromodomain helicase DNA-binding domain 2 (Chd2), a SNF2 chromatin remodelling enzyme family member, interacts with MyoD and myogenic gene regulatory sequences to specifically mark these loci via deposition of the histone variant H3.3 prior to cell differentiation. Directed and genome-wide analysis of endogenous H3.3 incorporation demonstrates that knockdown of Chd2 prevents H3.3 deposition at differentiation-dependent, but not housekeeping, genes and inhibits myogenic gene activation. The data indicate that MyoD determines cell fate and facilitates differentiation-dependent gene expression through Chd2-dependent deposition of H3.3 at myogenic loci prior to differentiation.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Bio Entities

Trail: Publication

0 Expression